Combination of liraglutide and sitagliptin therapy improves glycemic control in Japanese patients with type 2 diabetes mellitus

Anticipatory guidance and systematic review of prescribing combination incretin therapy in the treatment of type 2 diabetes

“…Matsuhashi and colleagues found a significant decrease in HbA1c when sitagliptin 50 mg once daily was added to liraglutide 0.9 mg once daily in Japanese patients with uncontrolled T2DM, although the authors have not published finalized results at the time of writing 10 . Changes in body weight were not available at the time of writing, although the authors noted that an improvement in glycaemic control correlated with a reduction in body fat mass 10 …”